Judge orders CDC, FDA to restore websites taken down
On December 27, 2024, the US Food and Drug Administration (FDA) published its final rule to update the definition for “healthy” claims on food ...
Recent federal developments may soon require cosmetic companies to adopt stringent precautions to ensure that talc-containing ...
While a pause on federal health agencies is nothing new during presidential transitions, the Trump Administration’s ...
The FDA removed previously issued draft guidance on diversity in clinical trials from its website without public notice or ...
Changes to the FDA labeling guidance in support of FALCPA include alterations to the definitions of “major” food allergens ...
The FDA issued a warning letter to ProRx, a compounding facility in Exton, Penn., after an inspection raised serious concerns regarding the safety and compliance of its drug products. The facility, ...
A group of health care experts said that if the Arizona Supreme Court issues a death warrant, it would trigger "a cascade of ...
SANTA ANA, Calif. - NKGen Biotech, Inc. (NASDAQ: NKGN), a clinical-stage biotechnology company with a current market capitalization of $17 million, has received Fast Track designation from the U.S.
From the founders of BoldType comes CyberMed, a new company dedicated exclusively to MedTech cybersecurity. With a mission to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results